LBXpro
Ollin logo

Ollin

ollin.bio

Developer of ophthalmic therapeutics designed to treat vision-threatening eye diseases and preserve patient vision.

Last Round
Jun 2026
$3.00
Series B · $900.0M

Price per share

12M · USD

Loading chart...

Funding history

$M raised · $B post-money

Loading chart...
LBXpro

Stay in the loop

Get private market insights and platform updates delivered to your inbox.

Office

Building A1, Dubai Digital Park, Dubai Silicon Oasis, Dubai, United Arab Emirates

Contact

leo@lbx.pro

Nothing on this site and the investment platform is intended as an offer to purchase or sell securities or a solicitation or recommendation of our securities transaction. Any financial information presented on the site and the investment platform are opinions, were prepared without taking into account your objectives, financial situation or needs. Investment results are not guarantees of future results.

© All rights reservedPrivacy PolicyTerms of ServiceRisk DisclosureCookie Policy

Leo

AI analyst

Ask anything

Companies, valuations, IPO plans, market activity